鼻敏康治疗过敏性鼻炎的临床与实验研究  

Clinical and Experimental Study for Allergic Rhinitis with Treatment of Biminkang Mixture

作　　者：包力[1] 孙起文[1] 胡麟[1] 徐新玉[1] 孔令新[1] 赵华[1] 陈志婵[1] 

机构地区：[1]兰州军区乌鲁木齐总医院

出　　处：《中国中西医结合杂志》1997年第2期70-72,共3页Chinese Journal of Integrated Traditional and Western Medicine

摘　　要：目的：以新疆哈萨克族民间草药一枝蒿（ＡｒｔｅｍｉｓｔａｒｕｐｅｓｔｒｉｓＬ．）为主药制成中药鼻敏康合剂。治疗过敏性鼻炎１６４例。方法：与成药鼻炎康治疗５２例作为对照。结果：显示两组总有效率分别为９３．９％和６９．２％，停药后复发率分别为４６．８％和８７．及％。结论：表明鼻敏康近、远期疗效均明显优于鼻炎康（Ｐ均＜０．０１）。药效实验证实鼻敏康具有明显的抗组织胺、抑制Ⅰ型变态反应和稳定肥大细胞膜作用。To observe the efficacy of Biminkang in treating allergic rhinitis. Methods: One hun dred and sixty-four cases of allergic rhinitis were treated with the Chinese medicine Biminkang mix ture mainly consisted of the Kazak folk herb Artemisia rupestis L.and in 52 cases of allergic rhinitiswere treated as the control with the Patent medicine Biyankang. Results: The total effective rates inboth grouch are 93. 9% and 69. 2% respectively. After stopping the medications, the recurrencerates were 46. 8 % and 87. 1 %. Biminkang was better than Biyankang in short or long term of effec tiveness (P<0. 01 ). Pharmacological study demonstrated Biminkang played a significant role of re sisting histamine, inhibiting allergic reaction I and stubilising cell membrane of maStocyte. Conclu sion: Biminkang mixture is an effective drug in treating allergic rhinitis.

关 键 词：过敏性鼻炎 鼻敏康合剂 中医药疗法 

分 类 号：R276.152.1[医药卫生—中医五官科学]